Table 2 Significant differences of plasma lipoproteins in PKU patients and controls (t-test). Explanation of terminology is presented in Table S1
Lipoprotein | Controls (n = 14) | Patients (n = 20) | p-value | ||
|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
L2AB [mg/dL] | 9.6 | 2.8 | 5.2 | 2.9 | 0.00005 |
L2PN [nmol/L] | 173.9 | 51.6 | 93.9 | 53.5 | 0.00005 |
L2PL [mg/dL] | 9.7 | 2.6 | 5.4 | 3.1 | 0.00007 |
L2CH [mg/dL] | 17 | 5.5 | 8.3 | 6.4 | 0.00009 |
L2FC [mg/dL] | 5.4 | 1.6 | 3.1 | 2 | 0.00053 |
L1CH [mg/dL] | 24.8 | 3.8 | 18.2 | 6.4 | 0.00078 |
L1AB [mg/dL] | 13.2 | 2 | 10.2 | 2.9 | 0.00105 |
L1PN [nmol/L] | 239.1 | 36.6 | 185.1 | 53.2 | 0.00106 |
L1PL [mg/dL] | 14.2 | 2 | 11.2 | 3 | 0.00115 |
L1FC [mg/dL] | 7.4 | 1.3 | 5.6 | 2 | 0.00239 |
LDPL [mg/dL] | 60.9 | 14.2 | 48.9 | 10.9 | 0.00368 |
LDCH [mg/dL] | 104.1 | 30 | 79.5 | 21.8 | 0.00382 |
LDFC [mg/dL] | 31 | 7.8 | 24.1 | 6.9 | 0.00414 |
L3CH [mg/dL] | 14.5 | 7 | 8.6 | 5.6 | 0.0045 |
L3AB [mg/dL] | 8.7 | 3.9 | 5.5 | 3.1 | 0.00554 |
L3PN [nmol/L] | 158 | 71.6 | 100.6 | 56.1 | 0.00555 |
L3PL [mg/dL] | 8.5 | 3.5 | 5.5 | 3 | 0.00579 |
LDPN [nmol/L] | 1229.8 | 335.9 | 994.6 | 224 | 0.00815 |
LDAB [mg/dL] | 67.6 | 18.5 | 54.7 | 12.3 | 0.00815 |
L3TG [mg/dL] | 2.5 | 0.7 | 2 | 0.7 | 0.01909 |
L3FC [mg/dL] | 4.6 | 1.7 | 3.3 | 1.8 | 0.0219 |
TPCH [mg/dL] | 201 | 33.2 | 179.4 | 28.1 | 0.02204 |